AI-Powered Patient Recruitment
Accelerate your clinical trial recruitment with our innovative AI technology and global patient network
AI-Powered Recruitment
Our advanced AI technology revolutionizes patient recruitment through intelligent matching and optimization
Smart Patient Matching
Our AI analyzes complex eligibility criteria and matches them with patient profiles in real-time, increasing screening efficiency by 60%.
Predictive Analytics
Machine learning algorithms predict recruitment trends and identify optimal recruitment channels for different patient populations.
Natural Language Processing
Advanced NLP technology extracts relevant patient information from medical records and documents automatically.
Real-time Optimization
AI continuously optimizes recruitment strategies based on performance data and patient engagement metrics.
Multi-Channel Recruitment
Reach potential participants through multiple optimized channels
Digital Outreach
Targeted social media campaigns and digital advertising using AI-driven audience segmentation.
Healthcare Networks
Partnerships with healthcare providers and clinics for direct patient referrals.
Patient Communities
Engagement with online patient communities and support groups.
Database Mining
Intelligent analysis of existing patient databases and health records.
Our Recruitment Process
A streamlined approach to finding and enrolling the right participants
Protocol Analysis
AI analyzes your protocol to identify ideal patient profiles and recruitment strategies
Patient Identification
Smart matching technology identifies potential participants across multiple channels
Pre-screening
Automated pre-screening ensures candidates meet basic eligibility criteria
Enrollment Support
Dedicated support team assists with final screening and enrollment
Sponsor Testimonials
"Outstanding support and real-time analytics that helped us optimize our recruitment strategy for rare disease trials. The diversity initiatives have transformed our patient population."
Emily T.
Head of Clinical Operations
Research Site
"The patient diversity in our Phase III cardiovascular trial exceeded our expectations, with representation across all key demographic groups. This has significantly strengthened our submission data."
James W.
Clinical Development Lead
Research Site
Why Choose TheraNovex
See what makes our approach to patient recruitment different
How does TheraNovex accelerate patient recruitment for clinical trials?
We use AI-powered matching technology combined with multi-channel outreach strategies to identify and engage qualified patients quickly and efficiently for clinical trials across therapeutic areas including oncology, neurology, and rare diseases. Our approach has shown to reduce recruitment timelines by up to 40% compared to traditional methods.
What therapeutic areas does TheraNovex specialize in?
TheraNovex specializes in multiple therapeutic areas including oncology, neurology, cardiovascular diseases, immunology, metabolic disorders, and rare diseases. Our platform is designed to handle the unique recruitment challenges of each therapeutic area.
How does TheraNovex ensure diverse patient representation in clinical trials?
We employ targeted outreach strategies to underrepresented communities, partner with diverse healthcare providers, use inclusive eligibility criteria, and leverage our AI technology to identify diversity gaps and optimize recruitment efforts accordingly.
What makes TheraNovex's recruitment approach different from other services?
Our unique combination of AI-powered patient matching, multi-channel recruitment strategies, global site network, and real-time analytics platform sets us apart from traditional recruitment services. We focus on quality matches rather than quantity of referrals.
In which geographic regions does TheraNovex operate?
TheraNovex operates globally with a strong presence in North America, Europe, Asia-Pacific, and parts of Latin America and Africa. Our platform supports multi-language capabilities and culturally adapted recruitment strategies for each region.